IQVIA expands use of Veeva tools to speed clinical trials

IQVIA and Veeva Systems announced an expansion of their collaboration, with Veeva CTMS, eTMF, Study Startup, and Site Connect designated as enterprise standard applications across IQVIA’s clinical development studies. The move follows an existing emphasis on an integrated technology stack to speed trials and improve site-centric operations, potentially helping patients access new treatments faster.

What changed

IQVIA and Veeva said they will use a broader set of Veeva tools across their clinical studies. The tools named are CTMS (Clinical Trial Management System), eTMF (electronic Trial Master File), Study Startup, and Site Connect. An earlier announcement already included an electronic data capture (EDC) partnership. The combined setup is described as enterprise standard, meaning these tools will be used widely within IQVIA's trials.

Who is affected

Clinical researchers, trial sponsors working with IQVIA, and participating study sites may experience changes in how trials are organized and managed. The intent is to create a more connected workflow across planning, site work, and data management, with the aim of making trial processes smoother for site staff and quicker to generate reliable results.

Practical next steps

For researchers and site teams: expect ongoing access to integrated tools for trial planning, document management, and site communications as IQVIA progresses with deployment. Sponsors should anticipate potential improvements in trial setup speed and data visibility. If you use Veeva technology in trials, confirm how your current workflows align with the enterprise standard and whether any additional training or support is provided by IQVIA or Veeva through this expanded collaboration.

Limits and questions

The announcement summarizes strategic alignment and potential efficiency gains but does not provide specific performance metrics or rollout timelines. It also does not describe patient-level impacts or regulatory considerations in detail. Readers should monitor official IQVIA and Veeva communications for updates on deployment schedules, training resources, and any changes to data access or site responsibilities.

Information and responsibility notice: This article is general information based on the cited material available when published. It is not legal, tax, immigration, medical, financial, banking, or investment advice; it does not create a professional-client relationship; and it is not a guarantee of outcome, availability, accuracy, or eligibility. Rules, schedules, prices, and third-party information can change. Confirm material decisions with the relevant authority and an appropriately qualified adviser before acting.